@article{cartron:hal-04212199,
TITLE = {Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low--Tumor Burden Follicular Lymphoma: Results of a LYSA Study},
AUTHOR = {Cartron, Guillaume and Bachy, Emmanuel and Tilly, Herv{\'e} and Daguindau, Nicolas and Pica, Gian-Matteo and Bijou, Fontanet and Mounier, Christiane and Clavert, Aline and Damaj, Gandhi Laurent and Slama, Borhane and Casasnovas, Olivier and Houot, Roch and Bouabdallah, Krimo and Sibon, David and Fitoussi, Olivier and Morineau, Nadine and Herbaux, Charles and Gastinne, Thomas and Fornecker, Luc-Matthieu and Haioun, Corinne and Launay, Vincent and Araujo, Carla and Benbrahim, Omar and Sanhes, Laurence and Gressin, Remy and Gonzalez, Hugo and Morschhauser, Franck and Ternant, David and Xerri, Luc and Tarte, Karin and Pranger, Delphine},
URL = {https://hal.science/hal-04212199},
JOURNAL = {Journal of Clinical Oncology},
PUBLISHER = {American Society of Clinical Oncology},
VOLUME = {41},
NUMBER = {19},
PAGES = {3523-3533},
YEAR = {2023},
DOI = {10.1200/JCO.22.02327},
PDF = {https://hal.science/hal-04212199/file/Cartron%20et%20al%20-2023-Randomized%20Phase%20III%20Trial%20Evaluating%20Sub-Cutaneous%20Rituximab%20for%20the%20First%20Line%20Treatment%20of%20Low-Tumor%20Burden%20Follicular%20Lymphoma%20%281%29.pdf},
HAL_ID = {hal-04212199},
HAL_VERSION = {v1},
}